top of page

Fundamentals of Psilocybin-Assisted Psychotherapy (NZ)

Delivered across two weekends, TheraPsil’s Fundamentals of Psilocybin-Assisted Therapy is a New Zealand-focused training for clinicians and professionals preparing to work in psychedelic-assisted care.

Course begins on 5 February 2027

Fundamentals of Psilocybin-Assisted Psychotherapy is delivered on New Zealand-friendly hours and is geared towards Kiwis looking for the legal, scientific, and healthcare knowledge necessary to deliver psilocybin treatments. With a particular emphasis on end-of-life care, the course comprises 11 Units, across the following times (NZST):

Friday, Feb 5th, 09:00 - 12:00

Saturday, Feb 6th, 09:00 - 15:00

Sunday, Feb 7th, 09:00 - 15:00

Friday, Feb 19th, 09:00 - 12:00

Saturday, Feb 20th, 09:00 - 15:00

Sunday, Feb 21st, 09:00 - 15:00

About the Program

This two-part psychedelic pathway is delivered live online for practitioners in New Zealand, covering everything from foundational theory to real-world practice. Designed for mental health, medical, supportive care, and allied professionals preparing to work with psilocybin-assisted psychotherapy, the 11-unit curriculum spans didactic foundations with NZ-specific content woven throughout training blocks. The program totals approximately 106.5 hours of engagement across live seminars, webinars, reading, reflection, and supervision.


Cohorts are intentionally kept small to foster meaningful discussion and close faculty involvement, with acceptance based on fit, scope, and readiness. This intimate structure ensures participants receive the depth of support needed to translate learning into practice.

TheraPsil4_edited.jpg

New Zealand Focus

The hallmark of this training is its specificity for Kiwi practitioners. Throughout the program, experts from New Zealand will guide you through these topics and more:​

  • Legal status of psilocybin in New Zealand

  • Advice for Section 29 applications

  • Festival harm reduction opportunities

  • Maori health/Hauora

  • Drug policy in New Zealand

  • Indigenous Psilocybe varieties in NZ

  • PAT's potential to align with Te Ao Maori, equitable access for Maori

  • New Zealand's first authorised prescriber, lessons learnt from the process

Who is it for?

This program is intended for practitioners engaging in or preparing for psilocybin-assisted psychotherapy within mental health, medical, and supportive care contexts. As such, we require each participant to hold one of the following: a medical degree (MD, RN); a graduate degree (MA, PhD) in psychology, counselling psychology, or a closely related field (e.g., psychiatric social work [RSW] or psychiatric nursing [RPN]); naturopathic medicine (ND); paramedicine (e.g., paramedics, first responders); death doula training; a credential in osteopathic or chiropractic practice (e.g., DOMP, DO, DC); or a graduate diploma in a related field.

​

Each applicant will be admitted to the training program following a successful interview with the Director of Training and Operations to assess personal and professional suitability.

TheraPsil5.jpeg
Psychedelic-Assisted Therapy

Learning Outcomes

  • Understand the legal and ethical landscape in Aotearoa New Zealand, including authorised prescriber pathways.

  • Apply TheraPsil’s intake, assessment, inclusion criteria, and follow-up protocol to identify who may benefit.

  • Build preparation, dosing-session support, and integration skills using trauma-aware frameworks.

  • Develop competency in neuropharmacology, medication interactions, contraindications, and risk mitigation.

  • Work skillfully with end-of-life distress and complex presentations, including family support and palliative care considerations.

  • Engage with NZ cultural dimensions, including Māori health, equity, and local realities.

Drug Science Background 6.png

“The relational, personal, and experiential aspects of the week were nothing short of transformative. The week went far beyond conventional learning outcomes, it was healing, connective, and life affirming.”

Steph Blyth, RCC, MDiv

“The content was incredibly useful and integrated beautifully into my practice. As someone with years of plant medicine experience, I still learned so much.”

Dawn Slykhuis, MSW, RSW

“This is an excellent program for learning how to prepare, support, and help clients integrate psychedelic assisted therapy. The online course was very well done, and a great way to access this pioneering information.”

Online Training Attendee

Course Outline

Unit 1

​

Navigating psilocybin access in Aotearoa, legal frameworks, advocacy, and prescribing pathways

Unit 2

​

History of clinical research in psychedelic therapy, current evidence, and directions forward

Unit 3

​

Psychedelic neuropharmacology, drug interactions, contraindications, and de-prescribing considerations

Unit 4

​

Models of change, mystical experience, COEX, and contemporary frameworks including REBUS

Unit 5

​

Preparation and integration sessions, set and setting, readiness, intention, and integration groups

Unit 6

​

The dosing session, roles, music, safety, challenging sessions, and case study review

Unit 7

​

Therapeutic relationship, boundaries, co-therapy, self-care, and ethics

Unit 8

​

Palliative care in psychedelic psychotherapy, end-of-life distress, family support, death literacy

Unit 9

​

NZ clinical and cultural dimensions, Māori health, equity, harm reduction realities, local knowledge

Unit 10

​

Complementary modalities including breathwork, creative arts, bodywork, and adjunctive frameworks

Unit 11

​

Clinical supervision minimums, mentoring, and supervised transition into practice (minimum 10 hours)

New Zealand Faculty

David Nutt Headshot

Prof David Nutt

Psychedelic science

Suresh Muthukumaraswamy.jpg

Prof Suresh Muthukumaraswamy

Neuroimaging and psychedelic research

Musheerah.jpg

Musheerah Nuha

Pasifika healthcare perspectives

Stuart McDonald_edited.jpg

Stuart McDonald

Māori cultural frameworks for healing

James Simonsson.jpg

Dr James Andrew Simonsson

Psychiatry and indigenous mental health

Sam Lasham.webp

Sam Lasham

Mushroom species of Aotearoa

James Bunn.jpg

James Bunn

Legal status of psychedlic Medicines in New Zealand

Adam-Waugh-Circle.webp

Adam Waugh

Festival harm reduction

  • Dave Phillips.png

    Dave Phillips

    Lead trainer

    Rohini Kanniganti.png

    Dr. Rohini Kanniganti

    Palliative care

    Jagpaul Deol.png

    Jagpaul Deol

    Neuropharmacology

    Kylea Taylor.png

    Kylea Taylor

    Ethics

    Carla-Pauls.webp

    Carla Pauls

    Assistant trainer

Drug Science Background 3.png

Enrol Now

$6,370 NZD

Payment plans and bursaries are available.

​

Once accepted, you must secure your spot with a $1,000 deposit, full tuition payment, or one of our payment plan options. Full tuition is required 12-weeks prior to training to grant access to all pre-training materials. Deposits are non-refundable.

​

Tuition includes a TheraPsil membership, complete with webinars, resources, community events, access to our legal team, and our Community of Care & Practice.

TheraPsil

Founded in 2019 by Dr. Bruce Tobin, TheraPsil emerged from a deep understanding of the mental health challenges faced by Canadians. Driven by a commitment to compassionate, human-centred care, TheraPsil is dedicated to helping Canadians access psychedelic-assisted psychotherapy with the support of qualified healthcare professionals.

​

TheraPsil works towards this goal by focusing on four strategic pillars: 

  • Advocacy and compassionate access

  • Education

  • Community

  • Research

TheraPsil Logo - High Res.png

Drug Science

Drug Science is the only completely independent, science-led drugs charity in the UK, uniquely bringing together leading drug experts from a wide range of specialisms to carry out ground-breaking research into drug harms and effects.

​

Drug Science works to provide an evidence base free from political or commercial influence, creating the foundation for sensible and effective drug laws, and equipping the public, media and policymakers with the knowledge and resources to enact positive change.

Hi-Res DS Logo

Psychedelic Training Centre NZ

The Psychedelic Training Centre NZ was established to ensure that professionals across Aotearoa have access to world-class, industry-leading psychedelic training. It is the first New Zealand-based organisation dedicated to equipping Kiwis with the knowledge and skills needed to work in psychedelic medicine.

PsyTrain Whiteout.png
Ahipoutu Collective

Ahipoutu Collective

The Ahipoutu Collective empowers rangatahi, whānau, and communities by weaving together traditional and contemporary Toi Māori. Through practices like tā-moko, whakairo, and pūrakau, the Collective blends ancient wisdom with modern creativity, fostering cultural growth, healing and connection.

bottom of page